SEARCH

SEARCH BY CITATION

References

  • 1
    Visakorpi JK. Changing features of coeliac disease. In: Mäki M, Collin P, Visakorpi JK, eds. Coeliac Disease. Tampere: Coeliac disease study group, 1997: 1–7.
  • 2
    Ascher H, Krantz I, Kristiansson B. Increasing incidence of coeliac disease in Sweden. Arch Dis Child 1991; 66: 608 11.
  • 3
    Mäki M, Holm K, Ascher H, Greco L. Factors affecting clinical presentation of coeliac disease: Role of type and amount of gluten-containing cereals in the diet. In: Auricchio S, Visakorpi JK, eds. Common Food Intolerances 1: Epidemiology of Coeliac Disease. Basel: Karger, 1992: 76–82.
  • 4
    Ascher H, Krantz I, Rydberg L, Nordin P, Kristiansson B. Influence of infant feeding and gluten intake on coeliac disease. Arch Dis Child 1997; 76: 113 17.
  • 5
    Catassi C, Fabiani E, Rätsch IM, et al. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr 1996; 85(Suppl. 412): 29 35.
  • 6
    Grodzinsky E, Franzen L, Hed J, Ström M. High prevalence of celiac disease in healthy adults revealed by antigliadin antibodies. Ann Allergy 1992; 69: 66 70.
  • 7
    Fasano A. Where have all the American celiacs gone? Acta Paediatr 1996; 85(Suppl. 412): 20 4.
  • 8
    Johnston SD, Watson RGP, McMillan SA, et al. Preliminary results from follow-up of a large scale population survey of antibodies to gliadin, reticulin and endomysium. Acta Paediatr 1996; 85(Suppl. 412): 61 4.
  • 9
    Catassi C, Rätsch I-M, Fabiani E, et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994; 343: 200 3.
  • 10
    Mäki M & Collin P. Coeliac disease. Lancet 1997; 349: 1755 59.
  • 11
    Ferguson A, Arranz E, O’Mahony S. Clinical and pathological spectrum of coeliac disease—active, silent, latent, potential. Gut 1993; 34: 150 1.
  • 12
    Gee S. On the coeliac disease. St Bart Hosp Rep 1888; 24: 17 20.
  • 13
    Dicke WK. Coeliakie. MD Thesis, Utrecht, 1950.
  • 14
    Dicke WK, Weijers HA, Van De Kamer JH. Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease. Acta Paediatr Scand 1953; 42: 34 42.
  • 15
    Van De Kamer JH, Weijers HA, Dicke WK. Coeliac disease. IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease. Acta Paediatr Scand 1953; 42: 223 31.
  • 16
    Janatuinen EK, Pikkarainen PH, Kemppainen TA, et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995; 333: 1033 37.
  • 17
    Srinivasan U, Leonard N, Jones E, et al. Absence of oats toxicity in adult coeliac disease. Br Med J 1996; 313: 1300 1.
  • 18
    Hardman CM, Garioch JJ, Leonard JN, et al. Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 1997; 337: 1884 7.
  • 19
    Sturgess R, Day P, Ellis HJ, et al. Wheat peptide challenge in coeliac disease. Lancet 1994; 343: 758 61.
  • 20
    Shidrawi RG, Day P, Przemioslo R, Ellis HJ, Nelufer JM, Ciclitira PJ. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture. Scand J Gastroenterol 1995; 30: 758–62.
  • 21
    Parnell NDJ, Ellis HJ, Ciclitira P. Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 1998; 338: 1470.
  • 22
    Sollid L, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer. J Exp Med 1989; 169: 345 50.
  • 23
    Tighe MR & Ciclitira PJ. The gluten–host interaction. In: Howdle PD, ed. Coeliac Disease. Bailliere’s Clinical Gastroenterology 1995; 9: 2: 211–30.
  • 24
    Marsh M, Bjarnason I, Shaw J, et al. Studies of intestinal lymphoid tissue. XIV-HLA status, mucosal morphology, permeability and epithelial lymphocyte populations in first degree relatives of patients with coeliac disease. Gut 1990; 31: 32 6.
  • 25
    Walker-Smith JA. Celiac disease. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, eds. Pediatric Intestinal Disease, Vol 2. Philadelphia: BC Decker, 1991: 700–18.
  • 26
    Greco L, Corazza G, Babron MC, et al. Genome search in celiac disease. Am J Human Genet 1998; 62: 669 75.
  • 27
    Lundin K, Scott H, Hansen T. Gliadin specific HLA-DQ (A1*0501, B1*0201) restricted T cells isolated from the small intestinal mucosa of coeliac patients. J Exp Med 1993; 178: 187 96.
  • 28
    Nilsen EM, Lundin KEA, Krajci P, et al. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferonγ. Gut 1995; 37: 766 76.
  • 29
    Johansen BH, Gjertsen HA, Vartdal H, et al. Binding of peptides from the N-terminal region of α-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T-cell assays. Clin Immunol Immunopathol 1996; 79: 288 93.
  • 30
    Shidrawi RG, Parnell NDJ, Ciclitira PJ, Travers P, Evan G, Rosen-Bronson S. Binding of gluten-derived peptides to the HLA-DQ2 (α1*0501, β1*0201) molecule, assessed in a cellular assay. Clin Exp Immunol 1998; 111: 158 65.
  • 31
    Gjertsen HA, Lundin KEA, Sollid LM, Eriksen JA, Thorsby E. T cells recognise a peptide derived from α-gliadin presented by the celiac disease-associated HLA-DQ (α1*0501, β1*0201) heterodimer. Human Immunol 1994; 39: 243 52.
  • 32
    Corazza GR & Gasbarrini G. Coeliac disease in adults. In: Howdle PD, ed. Coeliac Disease. Bailliere’s Clinical Gastroenterology 1995; 9: 2: 329–50.
  • 33
    Corazza GR, Frisoni M, Treggiari EA, et al. Subclinical celiac sprue: increasing occurrence and clues to its diagnosis. J Clin Gastroenterol 1993; 16: 16 21.
  • 34
    Thain ME, Hamilton JR, Erlich RM. Coexistence of diabetes mellitus and celiac disease. J Pediatr 1974; 85: 527 9.
  • 35
    Savilahti E, Simell O, Koskimies S, et al. Celiac disease in insulin-dependent diabetes mellitus. J Pediatr 1986; 108: 690 3.
  • 36
    Collin P, Reunala T, Pukkala E, et al. Coeliac disease—associated disorders and survival. Gut 1994; 35: 1215 18.
  • 37
    Chapman RWG, Laidlow JM, Colin-Jones D, Eade OE, Smith CL. Increased prevalence of epilepsy in coeliac disease. Br Med J 1978; 22: 250 1.
  • 38
    Holmes GKT. Non-malignant complications of coeliac disease. Acta Paediatr 1996; 412(Suppl.): 68 75.
  • 39
    Gobbi G, Bouquet F, Greco L, et al. Coeliac disease, epilepsy, and cerebral calcifications. Lancet 1992; 340: 439 43.
  • 40
    Cronin CC, Jackson LM, Feighery C, et al. Coeliac disease and epilepsy. Q J Med 1998; 91: 303 8.
  • 41
    Holmes GKT, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease—effect of a gluten free diet. Gut 1989; 30: 333 8.
  • 42
    Fry L. Dermatitis herpetiformis: from gut to skin, contributions to the nature of coeliac disease. In: Mäki M, Collin P, Visakorpi JK, eds. Coeliac Disease. Tampere: Coeliac disease study group, 1997: 67–74.
  • 43
    Walker-Smith JA. Discussion of diagnostic criteria for coeliac disease at Tampere meeting. In: Mäki M, Collin P, Visakorpi JK, eds. Coeliac Disease. Tampere: Coeliac disease study group, 1997: 191–3.
  • 44
    Meeuwisse GW. Diagnostic criteria in coeliac disease. Acta Paediatr Scand 1970; 59: 461 3.
  • 45
    Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for the diagnosis of coeliac disease. Report from a working group. Arch Dis Child 1990; 65: 909 11.
  • 46
    Howdle PD. Two biopsies for adults. In: Mäki M, Collin P, Visakorpi JK, eds. Coeliac Disease. Tampere: Coeliac disease study group, 1997: 185–8.
  • 47
    Trier JS. Celiac sprue. N Engl J Med 1991; 325: 1373 4.
  • 48
    Howdle PD & Losowsky MS. Coeliac disease in adults. In: Marsh MN, ed. Coeliac Disease. Oxford: Blackwell Scientific Publications, 1992: 49–80.
  • 49
    Grefte JMM, Bouman JG, Grond J, Jansen W, Kleibeuker JH. Slow and incomplete histological and functional recovery in adult gluten sensitive enteropathy. J Clin Pathol 1988; 41: 886 91.
  • 50
    Ferreira M, Lloyd Davies S, Butler M, Scott D, Clark M, Kumar P. Endomysial antibody: is it the best screening test for coeliac disease? Gut 1992; 33: 1633 7.
  • 51
    Lerner A, Kumar V, Iancu TC. Immunological diagnosis of childhood coeliac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies. Clin Exp Immunol 1994; 95: 78 82.
  • 52
    Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994; 35: 776 8.
  • 53
    Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797 801.
  • 54
    Molberg Ø, McAdam SN, Körner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713 17.
  • 55
    Ellis HJ, Freedman AR, Ciclitira PJ. Detection and estimation of the barley prolamin content of beer and malt to assess their suitability for patients with coeliac disease. Clin Chim Acta 1990; 189: 123 30.
  • 56
    Ellis HJ, Doyle AP, Day P, Wieser H, Ciclitira PJ. Demonstration of the presence of coeliac-activating gliadin-like epitopes in malted barley. Int Arch Allergy Immunol 1994; 104: 308 10.
  • 57
    Ellis HJ, Parnell NDJ, Ciclitira PJ. Cornflakes and coeliac disease. Gut 1998; 42(Suppl. 1): A35(Abstract).
  • 58
    O’Mahony S, Howdle PD, Losowsky MS. Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 1996; 10: 671 80.
  • 59
    Adlersberg D, Colcher H, Drachman SR. Studies on the effects of cortisone pituitary adrenocorticotrophic hormone (ACTH) in the sprue syndrome. Gastroenterology 1951; 19: 674 97.
  • 60
    Wall AJ, Douglas AP, Booth CC, Pearse AGE. Response of the jejunal mucosa in adult coeliac disease to oral prednisolone. Gut 1970; 11: 7 14.
  • 61
    Jones PE & Gleeson MH. Mucosal ulceration and mesenteric lymphadenopathy in coeliac disease. Br Med J 1973; 3: 212 13.
  • 62
    Hamilton JD, Chambers RA, Wynn-Williams A. Role of gluten, prednisone, and azathioprine in non-responsive coeliac disease. Lancet 1976; 1: 1213 16.
  • 63
    Logan RFA, Rifkind EA, Turner ID, Ferguson A. Mortality in celiac disease. Gastroenterology 1989; 97: 265 71.
  • 64
    Fairley NH & Mackie FP. The clinical and biochemical syndrome in lymphadenoma and allied diseases involving the mesenteric glands. Br Med J 1937; 1: 375 80.
  • 65
    Gough KR, Read AE, Naish JM. Intestinal reticulosis as a complication of idiopathic steatorrhoea. Gut 1962; 3: 232 9.
  • 66
    Isaacson PG & Wright DH. Malignant histiocytosis of the intestine: its relationship to malabsorption and ulcerative jejunitis. Human Pathol 1978; 9: 661 77.
  • 67
    Isaacson PG, Jones DB, Sworn MJ, Wright DH. Malignant histiocytosis of the intestine: report of three cases with immunological and cytochemical analysis. J Clin Pathol 1982; 35: 510 16.
  • 68
    Isaacson PG, O’Connor NTJ, Spencer J, et al. Malignant histiocytosis of the intestine: a T cell lymphoma. Lancet 1985; ii: 688 91.
  • 69
    Wright DH. The major complications of coeliac disease. In: Howdle PD, ed. Coeliac Disease. Bailliere’s Clinical Gastroenterology 1995; 9: 2: 351–69.
  • 70
    Holmes GKT & Thompson H. Malignancy as a complication of coeliac disease. In: Marsh MN, ed. Coeliac Disease. Oxford: Blackwell Scientific Publications, 1992: 105–35.
  • 71
    Egan LJ, Walsh SV, Stevens FM, Connolly CE, Egan EL, McCarthy CF. Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era. J Clin Gastroenterol 1995; 21: 123 9.
  • 72
    Swinson CM, Slavin G, Coles EC, Booth CC. Coeliac disease and malignancy. Lancet 1983 I. 111–15.
  • 73
    Kingham JG, Ramanaden D, Dawson A. Metachronous small-bowel adenocarcinoma in coeliac disease: Gluten-free diet is not protective. Scand J Gastroenterol 1998; 33: 218 22.
  • 74
    Mills PR, Brown IL, Watkinson G. Idiopoathic chronic ulcerative enteritis. Q J Med 1980; XLIX (194): 133–49.
  • 75
    Jeffries GH, Steinberg H, Sleisenger MH. Chronic ulcerative (nongranulomatous) jejunitis. Am J Med 1968; 44: 47 59.
  • 76
    Modigliani R, Poitras P, Galian A, et al. Chronic non-specific ulcerative duodenojejunoileitis: report of four cases. Gut 1979; 20: 318 28.
  • 77
    Baer AN, Bayless TM, Yardley JH. Intestinal ulceration and malabsorption syndromes. Gastroenterology 1980; 79: 754 65.
  • 78
    Biagi F, Poggioli G, Mazzoni G, Corazza GR. Case report: Intestinal strictures. Lancet, 1998; 352: 876.
  • 79
    Green JA, Barkin JS, Gregg PA, Kohen K. Ulcerative jejunitis in refractory celiac disease: enteroscopic visualization. Gastrointest Endosc 1993; 39: 584 5.
  • 80
    Enns R, Lay T, Bridges R. Use of azathioprine for nongranulomatous ulcerative jejunoileitis. Can J Gastroenterol 1997; 11: 503 6.
  • 81
    Isaacson P & Wright DH. Malignant histiocytosis of the intestine. Its relationship to malabsorption and ulcerative jejunitis. Human Pathol 1978; 9: 661 77.
  • 82
    Ashton-Key M, Diss TC, Pan L, Du MQ, Isaacson PG. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol 1997; 151: 493 8.
  • 83
    Bennett TI, Hunter D, Vaughan JM. Idiopathic steatorrhoea (Gee’s disease). A nutritional disturbance associated with tetany, osteomalacia and anaemia. Q J Med 1932; 1: 603 77.
  • 84
    Cooke WT & Holmes GKT. Clinical presentation. In: Coeliac Disease. Edinburgh: Churchill Livingstone, 1984: 90–5.
  • 85
    Corazza GR, Di Sario A, Ceccheti L, et al. Bone mass and metabolism in patients with celiac disease. Gastroenterology 1995; 109: 122 8.
  • 86
    Walters JR, Banks LM, Butcher GP, Fowler CR. Detection of low bone mineral density by dual energy X-ray absorptiometry in unsuspected suboptimally treated coeliac disease. Gut 1995; 37: 220 4.
  • 87
    Pistorius LR, Sweidan WH, Purdie DW, et al. Coeliac disease and bone mineral density in adult female patients. Gut 1995; 37: 639 42.
  • 88
    Walters JRF. Bone mineral density in coeliac disease. Gut 1994; 35: 150 1.
  • 89
    McFarlane XA, Bhalla AK, Reeves DE, Morgan LM, Robertson DA. Osteoporosis in treated adult coeliac disease. Gut 1995; 36: 710 14.
  • 90
    Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137 41.
  • 91
    Lindh E, Ljunghall S, Larsson K, Lavo B. Screening for antibodies against gliadin in patients with osteoporosis. J Intern Med 1992; 231: 403 6.
  • 92
    Molteni N, Caraceni MP, Bardella MT, Ortolani S, Gandolini GG, Bianchi P. Bone mineral density in adult celiac patients and the effect of gluten-free diet from childhood. Am J Gastroenterol 1990; 85: 51 3.
  • 93
    Caraceni MP, Molteni N, Bardella MT, Ortolani S, Nogara A, Bianchi PA. Bone and mineral metabolism in adult celiac disease. Am J Gastroenterol 1988; 83: 274 7.
  • 94
    Valdimarsson T, Löfman O, Toss G, Ström M. Reversal of osteopenia with diet in adult coeliac disease. Gut 1996; 38: 322 7.
  • 95
    McFarlane XA, Bhalla AK, Robertson DA. Effect of a gluten free diet on osteopenia in adults with newly diagnosed coeliac disease. Gut 1996; 39: 180 4.
  • 96
    Mautalen C, Gonzalez D, Mazure R, et al. Effect of treatment on bone mass, mineral metabolism, and body composition in untreated celiac disease patients. Am J Gastroenterol 1997; 92: 313 18.
  • 97
    Bai JC, Gonzalez D, Mautalen C, et al. Long-term effect of gluten restriction on bone mineral density of patients with coeliac disease. Aliment Pharmacol Ther 1997; 11: 157 64.
  • 98
    Valdimarsson T, Toss G, Ross I, Löfman O, Ström M. Bone mineral density in coeliac disease. Scand J Gastroenterol 1994; 29: 457 61.
  • 99
    Mora S, Barera G, Ricotti A, Weber G, Bianchi C, Chiumello G. Reversal of low bone density with a gluten-free diet in children and adolescents with celiac disease. Am J Clin Nutr 1998; 67: 477 81.
  • 100
    Marsh MN. Bone disease and gluten sensitivity: time to act, to treat, and to prevent. Am J Gastroenterol 1994; 89: 2105 7.
  • 101
    Riggs BL & Melton LJ III. The prevention and treatment of osteoporosis. N Engl J Med 1992; 327: 620 7.
  • 102
    Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med 1998; 338: 736 46.
  • 103
    Corazza GR, Amorosa L, Strocchi A, et al. Assessment of prevalence, familial occurrence, and possible factors inducing splenic hypofunction in adult coeliac disease in Italy. Gut 1989; 30: A1452 3(Abstract).
  • 104
    O’Grady JG, Stevens FM, Harding B, et al. Hyposplenism and gluten-sensitive enteropathy. Natural history, incidence, and relationship to diet and small bowel morphology. Gastroenterology 1984; 87: 1325 31.
  • 105
    Ferguson A, Hutton MM, Maxwell JD, Murray D. Adult coeliac disease in hyposplenic patients. Lancet 1970; i: 163–4.
  • 106
    Corazza GR, Frisoni M, Vaira D, Gasbarrini G. Effect of gluten-free diet on splenic hypofunction of adult coeliac disease. Gut 1983; 24: 228 30.
  • 107
    Corazza GR, Biagi F, Volta U, et al. Non-malignant complications of coeliac disease. In: Mäki M, Collin P, Visakorpi JK, eds. Coeliac Disease. Tampere: Coeliac Disease Study Group, 1997: 95–6.
  • 108
    Mayberry JF. Managing coeliac disease. Int J Gastroenterol 1997; 2: 9 11.